Coronary Laser Atherectomy Registry From an International Taskforce
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCeric Sàrl
About this trial
This study is a prospective, investigator-initiated, multi-center, single arm, observational registry of performance of Excimer Laser Coronary Atherectomy (ELCA) in standard use cases of percutaneous coronary intervention (PCI).
Eligibility criteria
Qualifiers
Age 18 years or over
Patient willing to be included in the registry
Patients with stable coronary artery disease or acute coronary syndromes with de-novo or intra-stent restenosis (ISR) coronary lesions suitable to be treated with ELCA
Crossable with ICI catheter with significant calcium score suggesting need for calcium modification based on IVUS or OCT criteria and/or
Disqualifiers
Pregnant or breast feeding
Unable to give informed consent
PCI performed without IVCI attempt
No ELCA use
Trial design
Treatments tested in this trial
- Excimer Laser Coronary Atherectomy (ELCA)
Treatment groups
No treatment groups listed
Locations
This trial has no locations
Sponsors and collaborators
Ceric Sàrl
Lead sponsor
Philips Medical Systems
Collaborator
European Cardiovascular Research Center
Collaborator
Source ClinicalTrials.gov